- Home
- KRMD vs VXRT Comparison
KRMD vs VXRT Comparison
Compare KRMD & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- VXRT
- Stock Information
- Founded
- KRMD 1980
- VXRT N/A
- Country
- KRMD United States
- VXRT United States
- Employees
- KRMD N/A
- VXRT N/A
- Industry
- KRMD Medical/Dental Instruments
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRMD Health Care
- VXRT Health Care
- Exchange
- KRMD Nasdaq
- VXRT Nasdaq
- Market Cap
- KRMD 134.3M
- VXRT 119.0M
- IPO Year
- KRMD N/A
- VXRT N/A
- Fundamental
- Price
- KRMD $2.79
- VXRT $0.45
- Analyst Decision
- KRMD Strong Buy
- VXRT Strong Buy
- Analyst Count
- KRMD 4
- VXRT 2
- Target Price
- KRMD $4.63
- VXRT $3.00
- AVG Volume (30 Days)
- KRMD 131.4K
- VXRT 1.8M
- Earning Date
- KRMD 05-07-2025
- VXRT 05-13-2025
- Dividend Yield
- KRMD N/A
- VXRT N/A
- EPS Growth
- KRMD N/A
- VXRT N/A
- EPS
- KRMD N/A
- VXRT N/A
- Revenue
- KRMD $35,083,740.00
- VXRT $47,395,000.00
- Revenue This Year
- KRMD $18.16
- VXRT N/A
- Revenue Next Year
- KRMD $14.60
- VXRT N/A
- P/E Ratio
- KRMD N/A
- VXRT N/A
- Revenue Growth
- KRMD 19.65
- VXRT 433.43
- 52 Week Low
- KRMD $1.86
- VXRT $0.29
- 52 Week High
- KRMD $5.05
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- KRMD 48.68
- VXRT 51.74
- Support Level
- KRMD $2.63
- VXRT $0.42
- Resistance Level
- KRMD $2.97
- VXRT $0.48
- Average True Range (ATR)
- KRMD 0.19
- VXRT 0.04
- MACD
- KRMD -0.03
- VXRT -0.00
- Stochastic Oscillator
- KRMD 24.44
- VXRT 47.06
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.